Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients

NCT03146247 is registered in ClinicalTrials.gov with Diamant Thaci as lead sponsor.

NCT NCT03146247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03146247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients
Lead sponsor
Diamant Thaci
Phase
Phase 4
Overall status
Withdrawn
Start date
October 23, 2017
Completion date
March 1, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe plaque psoriasis